Women Face Higher Risk for Severe AEs From Cancer Therapy
WEDNESDAY, Feb. 23, 2022 -- Women are at higher risk than men for severe cancer treatment-related adverse events (AEs), particularly for immunotherapy, according to a study published online Feb. 4 in the Journal of Clinical Oncology.
Joseph M....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Immunotherapy | Pharmaceuticals | Study | Women